Azaspirooctane-carboxylates as Novel Activators/Modulators of M4 for the Treatment of Alzheimer’s Disease and Parkinson’s Disease
Novel azaspirooctane-carboxylates are described for potential treatment of Alzheimer’s disease and Parkinson’s disease, among other conditions.
Gespeichert in:
Veröffentlicht in: | ACS medicinal chemistry letters 2024-11, Vol.15 (11), p.1830-1831 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1831 |
---|---|
container_issue | 11 |
container_start_page | 1830 |
container_title | ACS medicinal chemistry letters |
container_volume | 15 |
creator | Rosse, Gerard |
description | Novel azaspirooctane-carboxylates are described for potential treatment of Alzheimer’s disease and Parkinson’s disease, among other conditions. |
doi_str_mv | 10.1021/acsmedchemlett.4c00512 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3130830591</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3130830591</sourcerecordid><originalsourceid>FETCH-LOGICAL-a279t-bebdb0bfe71547a8c7f4c1c099ac6ccbda31076d9ab196d97262d816ef5e03a83</originalsourceid><addsrcrecordid>eNqFUbtOxDAQtBCI9y8glzQBOy_H5Ym3xAEF1NHG2egCSXx4nRNQ0fAR_B5fQo47EFRUu9qZndXsMLYnxYEUoTwEQy2WZoJtg94fxEaIRIYrbFPqOAuSTCWrv_oNtkV0L0SqlRLrbCPSSRplodpkb6MXoGntrDUeOgwMuMI-PTfgkTgQv7IzbPjI-HoG3jo6HNuyb75abis-jnllHfcT5LcOwbfY-fl81LxMsG7Rfby-Ez-uCYGQQ1fyG3APdUe2-43ssLUKGsLdZd1md6cnt0fnweX12cXR6DKAUGkfFFiUhSgqVDKJFWRGVbGRRmgNJjWmKCGSQqWlhkLqoagwDctMplglKCLIom22v9CdOvvYI_m8rclg0wzWbU95JCORRSLRcqCmC6pxlshhlU9d3YJ7zqXI5xHkfyPIlxEMi3vLG30x4D9r3z8fCOGCMAjk97Z33WD5P9VPz4idWw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3130830591</pqid></control><display><type>article</type><title>Azaspirooctane-carboxylates as Novel Activators/Modulators of M4 for the Treatment of Alzheimer’s Disease and Parkinson’s Disease</title><source>ACS Publications</source><creator>Rosse, Gerard</creator><creatorcontrib>Rosse, Gerard</creatorcontrib><description>Novel azaspirooctane-carboxylates are described for potential treatment of Alzheimer’s disease and Parkinson’s disease, among other conditions.</description><identifier>ISSN: 1948-5875</identifier><identifier>EISSN: 1948-5875</identifier><identifier>DOI: 10.1021/acsmedchemlett.4c00512</identifier><identifier>PMID: 39563827</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><ispartof>ACS medicinal chemistry letters, 2024-11, Vol.15 (11), p.1830-1831</ispartof><rights>Published 2024 by American Chemical Society</rights><rights>Published 2024 by American Chemical Society.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-a279t-bebdb0bfe71547a8c7f4c1c099ac6ccbda31076d9ab196d97262d816ef5e03a83</cites><orcidid>0000-0003-1993-3575</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.4c00512$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acsmedchemlett.4c00512$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2763,27075,27923,27924,56737,56787</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39563827$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rosse, Gerard</creatorcontrib><title>Azaspirooctane-carboxylates as Novel Activators/Modulators of M4 for the Treatment of Alzheimer’s Disease and Parkinson’s Disease</title><title>ACS medicinal chemistry letters</title><addtitle>ACS Med. Chem. Lett</addtitle><description>Novel azaspirooctane-carboxylates are described for potential treatment of Alzheimer’s disease and Parkinson’s disease, among other conditions.</description><issn>1948-5875</issn><issn>1948-5875</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqFUbtOxDAQtBCI9y8glzQBOy_H5Ym3xAEF1NHG2egCSXx4nRNQ0fAR_B5fQo47EFRUu9qZndXsMLYnxYEUoTwEQy2WZoJtg94fxEaIRIYrbFPqOAuSTCWrv_oNtkV0L0SqlRLrbCPSSRplodpkb6MXoGntrDUeOgwMuMI-PTfgkTgQv7IzbPjI-HoG3jo6HNuyb75abis-jnllHfcT5LcOwbfY-fl81LxMsG7Rfby-Ez-uCYGQQ1fyG3APdUe2-43ssLUKGsLdZd1md6cnt0fnweX12cXR6DKAUGkfFFiUhSgqVDKJFWRGVbGRRmgNJjWmKCGSQqWlhkLqoagwDctMplglKCLIom22v9CdOvvYI_m8rclg0wzWbU95JCORRSLRcqCmC6pxlshhlU9d3YJ7zqXI5xHkfyPIlxEMi3vLG30x4D9r3z8fCOGCMAjk97Z33WD5P9VPz4idWw</recordid><startdate>20241114</startdate><enddate>20241114</enddate><creator>Rosse, Gerard</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1993-3575</orcidid></search><sort><creationdate>20241114</creationdate><title>Azaspirooctane-carboxylates as Novel Activators/Modulators of M4 for the Treatment of Alzheimer’s Disease and Parkinson’s Disease</title><author>Rosse, Gerard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a279t-bebdb0bfe71547a8c7f4c1c099ac6ccbda31076d9ab196d97262d816ef5e03a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rosse, Gerard</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>ACS medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rosse, Gerard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Azaspirooctane-carboxylates as Novel Activators/Modulators of M4 for the Treatment of Alzheimer’s Disease and Parkinson’s Disease</atitle><jtitle>ACS medicinal chemistry letters</jtitle><addtitle>ACS Med. Chem. Lett</addtitle><date>2024-11-14</date><risdate>2024</risdate><volume>15</volume><issue>11</issue><spage>1830</spage><epage>1831</epage><pages>1830-1831</pages><issn>1948-5875</issn><eissn>1948-5875</eissn><abstract>Novel azaspirooctane-carboxylates are described for potential treatment of Alzheimer’s disease and Parkinson’s disease, among other conditions.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>39563827</pmid><doi>10.1021/acsmedchemlett.4c00512</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0003-1993-3575</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1948-5875 |
ispartof | ACS medicinal chemistry letters, 2024-11, Vol.15 (11), p.1830-1831 |
issn | 1948-5875 1948-5875 |
language | eng |
recordid | cdi_proquest_miscellaneous_3130830591 |
source | ACS Publications |
title | Azaspirooctane-carboxylates as Novel Activators/Modulators of M4 for the Treatment of Alzheimer’s Disease and Parkinson’s Disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T02%3A19%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Azaspirooctane-carboxylates%20as%20Novel%20Activators/Modulators%20of%20M4%20for%20the%20Treatment%20of%20Alzheimer%E2%80%99s%20Disease%20and%20Parkinson%E2%80%99s%20Disease&rft.jtitle=ACS%20medicinal%20chemistry%20letters&rft.au=Rosse,%20Gerard&rft.date=2024-11-14&rft.volume=15&rft.issue=11&rft.spage=1830&rft.epage=1831&rft.pages=1830-1831&rft.issn=1948-5875&rft.eissn=1948-5875&rft_id=info:doi/10.1021/acsmedchemlett.4c00512&rft_dat=%3Cproquest_cross%3E3130830591%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3130830591&rft_id=info:pmid/39563827&rfr_iscdi=true |